ACM Research Shanghai Inc (688082)
Shanghai Stock Exchange · China · prices in CNY · close of 19 Oct 2026
Key indicators
| Last close | CNY 246.50 |
|---|---|
| 52-week range | 138.23 – 458.90 |
| Return, 1 month / 3 months | −11.3% / −36.3% |
| Return, 1 year / 3 years | +34.8% / +134.3% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 35 |
| Volatility (1 year) | 68.9% |
| Worst drawdown (1 year) | -44.8% |
| Average daily value traded | 1,707.78M CNY |
| Dividend yield | 0.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
ACM Research Shanghai makes equipment used to manufacture semiconductors. Its machines clean and prepare silicon wafers during chip production, and it also builds tools for electroplating and other wet-processing steps. Customers are chipmakers and wafer fabrication plants that need these systems for their production lines. The company is based in Shanghai, China, and operates as part of the wider ACM Research group of semiconductor equipment businesses.
On this site ACM Research Shanghai Inc appears as a stock on the Shanghai Stock Exchange (China), code 688082, with prices in Chinese yuan (CNY). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
ACM Research Shanghai Inc (688082) trades on the Shanghai Stock Exchange in China. It last closed at CNY 246.50 on 19 October 2026.
Its price-based Market X-Ray is 58 out of 100 (a fair price profile), ranking 758 of 2,278 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 34.8% and over the last three months it fell 36.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Shanghai Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 72 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 3.8% | ||
| From 52-week high | -44.8% | ||
| Momentum | 65 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -36.3% | ||
| 6-month return | 60.5% | ||
| 12-month return, skipping the last month | 51.9% | ||
| Stability (higher is calmer) | 29 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 68.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -44.8% | ||
| Liquidity | 96 · Strong | Trades actively. | |
| Average daily value traded | 1,707.78M CNY | ||
| Zero-volume days | 0.0% | ||
| Income | 22 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.3% | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −6.7% |
|---|---|
| 1 month | −11.3% |
| 3 months | −36.3% |
| 6 months | +60.5% |
| 1 year | +34.8% |
| 3 years | +134.3% |
| 5 years | – |
Signals
| 50-day / 200-day average | 286.82 / 237.45 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 17.86 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 31 Jul 2026 | CNY 0.6202 |
| 1 Aug 2025 | CNY 0.6539 |
| 19 Jul 2024 | CNY 0.6264 |
| 21 Jul 2023 | CNY 0.3720 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Shanghai Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.